首页> 外文OA文献 >CALGB 30704 (Alliance): A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

【2h】

CALGB 30704 (Alliance): A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

机译：CALGB 30704（联盟）：一项评估培美曲塞或舒尼替尼或培美曲塞加舒尼替尼在晚期非小细胞肺癌二线治疗中疗效的随机II期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Heist Rebecca S.; Wang Xiaofei; Hodgson Lydia; Otterson Gregory A.; Stinchcombe Thomas E.; Gandhi Leena; Villalona-Calero Miguel A.; Watson Peter; Vokes Everett E.; Socinski Mark A.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CALGB 30704 (Alliance): A randomized phase ii study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer [J] . HeistR.S., WangX., HodgsonL., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2014,第2期

机译：CALGB 30704（联盟）：一项II期随机研究，评估培美曲塞或舒尼替尼或培美曲塞加舒尼替尼在晚期非小细胞肺癌二线治疗中的疗效
2. Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance) [J] . Ready Neal E., Pang Herbert H., Gu Lin, Journal of Clinical Oncology . 2015,第15期

机译：有或没有维持性舒尼替尼治疗未治疗的广泛期小细胞肺癌的化疗：一项随机，双盲，安慰剂对照的II期临床研究-CALGB 30504（联盟）
3. Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance) [J] . Ready Neal E., Pang Herbert H., Gu Lin, Journal of Clinical Oncology . 2015,第15期

机译：有或没有维护的化疗Sunitinib用于未经处理的广泛阶段的小细胞肺癌：随机，双盲，安慰剂控制第二阶段研究 - 卡格30504（联盟）
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer [O] . Rebecca S. Heist, Xiaofei Wang, Lydia Hodgson, -1

机译：评估培美曲塞或舒尼替尼或培美曲塞加舒尼替尼在晚期非小细胞肺癌二线治疗中的有效性的随机II期研究
7. Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance) [O] . Bogart, J, Vokes, EE, Graziano, SL, 2015

机译：化疗有或没有维持舒尼替尼用于未经治疗的广泛期小细胞肺癌：随机，双盲，安慰剂对照II期研究-CaLGB 30504（联盟）

CALGB 30704 (Alliance): A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

著录项

相似文献

相关主题

期刊订阅